CVS - CVS Health Corporation
| Previous Close | 74.53 |
| Open | 74.39 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 900 |
| Day's Range | 73.95 - 75.62 |
| 52 Week Range | 60.14 - 83.88 |
| Volume | 7,274,693 |
| Avg. Volume | 7,219,416 |
| Market Cap | 75.52B |
| Beta (3Y Monthly) | 0.90 |
| PE Ratio (TTM) | 25.26 |
| EPS (TTM) | 2.94 |
| Earnings Date | Nov 6, 2018 |
| Forward Dividend & Yield | 2.00 (2.69%) |
| Ex-Dividend Date | 2018-10-23 |
| 1y Target Est | 89.10 |
- Motley Fool•12 hours ago
3 Top Healthcare Stocks to Buy in October
It could be the perfect time to consider adding these top healthcare stocks to your portfolio.
- Investor's Business Daily•yesterday
IBD Stock Of The Day Cigna Nears Buy Point After Fighting Off Merger Doubts
Stock of The Day: Cigna battled doubters for months over its $67 billion Express Scripts takeover. Now, as the deal is almost done, Cigna stock is near a buy point.
- American City Business Journals•yesterday
NY regulators consider blocking parts of CVS, Aetna deal
New York state officials aren't happy with certain aspects of the $68 billion merger of drugstore store chain CVS Health Corp. and Aetna Inc. At a public hearing in Manhattan on Thursday, Maria Vullo — the superintendent of the state Department of Financial Services — said the deal could be blocked, and she called U.S. approval of the overall deal “myopic.” A major point of contention is that CVS and Aetna representatives have not provided written evidence that they would deliver on promises to lower the cost of prescription prices. Several groups, including the Pharmacists Society of the State of New York and the Medical Society of the State of New York, expect the merger will limit competition and make drugs more expensive. CVS and Aetna announced the deal in December 2017.
Markit•yesterdaySee what the IHS Markit Score report has to say about CVS Health Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- PR Newswire•2 days ago
CVS Pharmacy Completes Statewide Rollout of Time Delay Safes in Ohio Stores
WOONSOCKET, R.I., Oct. 18, 2018 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (CVS), announced today that it has begun using time delay safes in all of its 329 stores in Ohio, including pharmacies in Cleveland, Akron and Toledo. The safes help prevent pharmacy robberies and combat the ongoing opioid epidemic by keeping controlled substance narcotic medications from being misused or abused by keeping them out of the hands of unauthorized individuals.
- Investor's Business Daily•3 days ago
Best Mutual Funds Buying CVS, United, Lowe's And These Other Top Stocks
The best mutual funds have been heavily buying medical, transportation and retail stocks recently, with CVS, Biogen, United Airlines, Lowe's among the recipients.
- Zacks•4 days ago
CVS Health (CVS) Gains But Lags Market: What You Should Know
CVS Health (CVS) closed at $73.72 in the latest trading session, marking a +0.9% move from the prior day.
- GuruFocus.com•4 days ago
Dodge & Cox Stock Fund 3rd Quarter Commentary
The Dodge & Cox Stock Fund had a total return of 6.5% for the third quarter of 2018, compared to 7.7% for the S&P 500 Index. For the nine months ended September 30, 2018, the Fund had a total return of 7.5%, compared to 10.6% for the S&P 500. The S&P 500 was up 8%, reaching an all-time high in late September.
- CNBC•4 days ago
Walgreens wants to be seen as a health-care company, not just a retailer
It's not that being a retailer is a bad thing. But investors want drugstores to reinvent their businesses as Amazon already steals sales of everyday items like toilet paper and will soon enter the prescription drug delivery business with its acquisition of online pharmacy, Pillpack.
- PR Newswire•4 days ago
CVS Health to Embark on Pilot Program to Combat Diabetes in Medically Underserved Atlanta Neighborhoods
WOONSOCKET, R.I., Oct. 16, 2018 /PRNewswire/ -- CVS Health (CVS) announced today that it is embarking on a pilot project in the Tri-Cities area of Atlanta, Georgia, aimed at addressing diabetes in medically underserved communities with chronically high rates of this disease. In collaboration with Rimidi, Inc., a digital health company, and select community organizations, CVS Health will work to heighten awareness of diabetes and improve access to care among Tri-Cities area residents.
- Reuters•4 days ago
UnitedHealth forecasts 2019 profit gains after earnings beat
By Caroline Humer and Tamara Mathias (Reuters) - UnitedHealth Group Inc (UNH.N) on Tuesday backed Wall Street's 2019 earnings forecast, citing momentum in newer businesses like providing medical services ...
- PR Newswire•4 days ago
CVS Pharmacy Completes Rollout of Time Delay Safes in All Washington, DC Pharmacy Locations
WOONSOCKET, R.I., Oct. 16, 2018 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (CVS), announced today that it has completed the rollout of time delay safes in all of its 55 CVS Pharmacy locations in Washington, DC. The safes will help prevent pharmacy robberies and combat the ongoing opioid epidemic by helping to prevent diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals.
- PR Newswire•4 days ago
CVS Pharmacy Completes Rollout of Time Delay Safes in All of Its Maryland Pharmacies
WOONSOCKET, R.I., Oct. 16, 2018 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (CVS), announced today that it has completed the rollout of time delay safes in all of its 228 CVS Pharmacy locations in Maryland. The safes will help prevent pharmacy robberies and combat the ongoing opioid epidemic by helping to prevent diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals.
- Moody's•5 days ago
Rite Aid Corporation -- Moody's downgrades Rite-Aid to B3; outlook negative
Moody's Investors Service ("Moody's") today downgraded Rite Aid Corporation's Corporate Family Rating and probability of default rating to B3 and B3-PD from B2 and B2-PD respectively. Moody's ...
InvestorPlace•5 days ago2 Brick-and-Mortar Retail Stocks to Buy Now
With both retailers finding their own stride on the price charts to compliment attractive fundamentals, it’s time for a pair of bullish options strategies on FL stock and ULTA stock. Bottom line, as a strategic partner for a rebounding Nike (NYSE:NKE) and major channel supplier for Adidas (OTCMKT:ADDYY), Foot Locker is ground zero for cool sneakers and the kind of hands-on expertise many customers need to get into the right shoe. Many investors continue to fear a shift to online and direct-to-consumer channels by Foot Locker’s top brands will eventually sack FL stock once and for all.
- Zacks•5 days ago
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Market Realist•5 days ago
How Investors Reacted to Walgreens’s Fourth-Quarter Results
As we’ve already seen in this series, Walgreens Boots Alliance (WBA) posted better-than-expected fourth quarter of fiscal 2018 earnings yesterday but missed the top-line projections.
- PR Newswire•5 days ago
CVS Health Encourages Consumers to Safely Dispose of Prescription Drugs Ahead of National Prescription Drug Take-Back Day on October 27
WOONSOCKET, R.I., Oct. 15, 2018 /PRNewswire/ -- CVS Health (CVS) is encouraging consumers to clean out their medicine cabinets and safely dispose of unused prescription medication on National Prescription Drug Take-Back Day, this October 27. CVS Health has installed safe medication disposal units in more than 750 CVS Pharmacy locations nationwide and has donated more than 900 additional units to community locations such as police departments. Together, these units have collected more than 217 metric tons, or 480,000 pounds, of unwanted medication.
- InvestorPlace•8 days ago
DOJ Approval Means Time to Take Profits on Aetna Stock
In late October 2017, U.S. drugstore operator CVS Health Corp (NYSE:CVS) announced intentions to acquire U.S. health insurer Aetna Inc (NYSE:AET) in a $69 billion dollar deal that promised to permanently alter the healthcare industry. DOJ approval means that it is time to take profits on Aetna stock. Aetna stock initially jumped to nearly $200 by January 2018.
Market Realist•8 days agoCVS Gets Department of Justice Approval for Aetna Deal
On October 10, the US Department of Justice gave preliminary approval to the $69 billion deal between CVS Health (CVS) and Aetna (AET). CVS Health, America’s largest pharmacy chain, proposed the acquisition of Aetna, the country’s third-largest insurance company, in December 2017 for $207 per share. The clearance from the DOJ is among the most important milestones towards completing the deal.
- CNBC•9 days ago
Cramer's lightning round: Waving the red flag on Vodafone's stock
Jim Cramer shares his take on callers' favorite stock at lightning speed, including a telecommunications play that's starting to look suspicious.
Motley Fool•9 days agoWhy CVS Health, Fluor, and Square Slumped Today
Find out which of these stocks sank after what seemed like good news.
- Associated Press•9 days ago
CVS and Bank of America fall while Delta Air Lines climbs
Stocks that moved substantially or traded heavily Thursday: Square Inc., down $8.42 to $69.03 The mobile payments services company said Chief Financial Officer Sarah Friar will leave to become CEO of the ...
